store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ZED-1227 (TAK-227) 是一种具有口服活性、选择性和高效性的转谷氨酰胺酶 2 (TG2) 抑制剂,具有抗癌活性,能阻塞炎症诱导的 TG2 表达和激活,可用于治疗乳糜泻。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 2,890 | 现货 | ||
5 mg | ¥ 6,490 | 现货 | ||
10 mg | ¥ 8,750 | 现货 | ||
25 mg | ¥ 12,900 | 现货 | ||
50 mg | ¥ 17,500 | 现货 | ||
100 mg | ¥ 23,600 | 现货 |
产品描述 | ZED-1227 (TAK-227) is an orally active, selective and potent transglutaminase 2 (TG2) inhibitor with anticancer activity that blocks inflammation-induced TG2 expression and activation for the treatment of Celiac Disease. |
靶点活性 | TGase 2:45 nM |
体外活性 |
ZED-1227, at concentrations ranging from 0.1 μM to 1 μM for 24 hours, does not impact metabolic activity and proliferation in Huh7 cells and CaCo2 cells. This lack of effect suggests that ZED-1227 does not exhibit cytotoxic activity[1]. In an in vitro setting, ZED-1227, when applied at concentrations between 0.002 and 0.2 mg/mL for 30 minutes, inhibits transglutaminase 2 (TG2) in the small intestinal mucosa[1]. |
体内活性 | In mice, ZED-1227 reduces the activity of intestinal TG2 induced by Polyinosinic:Polycytidylic acid (40 mg/kg) to levels comparable to normal control levels. Additionally, ZED-1227 administration subdues intestinal inflammation in these mice[1].Furthermore, when administered orally (5 mg/kg; i.g.), ZED-1227 is effective in inhibiting TG2 in the small intestinal mucosa[1]. |
别名 | ZED-101, TAK-227 |
分子量 | 528.6 |
分子式 | C26H36N6O6 |
CAS No. | 1542132-88-6 |
store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (189.18 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.8918 mL | 9.4589 mL | 18.9179 mL | 47.2947 mL |
5 mM | 0.3784 mL | 1.8918 mL | 3.7836 mL | 9.4589 mL | |
10 mM | 0.1892 mL | 0.9459 mL | 1.8918 mL | 4.7295 mL | |
20 mM | 0.0946 mL | 0.4729 mL | 0.9459 mL | 2.3647 mL | |
50 mM | 0.0378 mL | 0.1892 mL | 0.3784 mL | 0.9459 mL | |
100 mM | 0.0189 mL | 0.0946 mL | 0.1892 mL | 0.4729 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
ZED-1227 1542132-88-6 Others Proteases/Proteasome Glutaminase ZED1227 ZED-101 ZED 1227 TAK-227 Inhibitor inhibitor inhibit